WRIGHT TIMOTHY MICHAEL 4
4 · Regulus Therapeutics Inc. · Filed Dec 5, 2017
Insider Transaction Report
Form 4
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-12-04+100,000→ 100,000 totalExercise: $3.30From: 2017-12-04Exp: 2026-10-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]On October 3, 2016, the reporting person was granted an option to purchase 400,000 shares of common stock. The option vests in increments of 100,000 shares upon the achievement of certain performance criteria. On December 4, 2017, the performance criteria for the first goal were met, resulting in the vesting of 100,000 shares.